Title: The Association between the Dietary Index for Gut Microbiota and Non- Alcoholic Fatty
Liver Disease: Evidence from NHANES 2017-2020
Version: 0 Date: 17 Feb 2025
Reviewer's report:
Overall, this paper is well done and has interesting subject matter. I have no major concerns
with the methodology. Belo two suggestions:
1 - If possible, I suggest that the authors use the new nomenclature and replace NAFLD with
MASLD.
2 - The authors could extend the scope of the research to understand how DI-GM affects liver
fibrosis in NAFLD/MASLD. This could be assessed using a non-invasive test (NIT) such as
VCTE (by LSM measurements) or FIB-4 (which includes age, AST, ALT and platelets) to detect
the presence of individuals at high risk of advanced fibrosis (FIB-4>2.67).
Title: The Association between the Dietary Index for Gut Microbiota and Non- Alcoholic Fatty
Liver Disease: Evidence from NHANES 2017-2020
Version: 0 Date: 17 Feb 2025
Reviewer's report:
Overall, this paper is well done and has interesting subject matter. I have no major concerns
with the methodology. Belo two suggestions:
1 - If possible, I suggest that the authors use the new nomenclature and replace NAFLD with
MASLD.
2 - The authors could extend the scope of the research to understand how DI-GM affects liver
fibrosis in NAFLD/MASLD. This could be assessed using a non-invasive test (NIT) such as
VCTE (by LSM measurements) or FIB-4 (which includes age, AST, ALT and platelets) to detect
the presence of individuals at high risk of advanced fibrosis (FIB-4>2.67).
Please review this paper.
user
Title: The Association between the Dietary Index for Gut Microbiota and Non- Alcoholic Fatty
Liver Disease: Evidence from NHANES 2017-2020
Version: 0 Date: 17 Feb 2025
Reviewer's report:
Overall, this paper is well done and has interesting subject matter. I have no major concerns
with the methodology. Belo two suggestions:
1 - If possible, I suggest that the authors use the new nomenclature and replace NAFLD with
MASLD.
2 - The authors could extend the scope of the research to understand how DI-GM affects liver
fibrosis in NAFLD/MASLD. This could be assessed using a non-invasive test (NIT) such as
VCTE (by LSM measurements) or FIB-4 (which includes age, AST, ALT and platelets) to detect
the presence of individuals at high risk of advanced fibrosis (FIB-4>2.67).
assistant